Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Leukemia 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Graft vs Host Disease 6Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Lymphoma, Mantle-Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Waldenstrom Macroglobulinemia 3Multiple Myeloma 3Hematologic Neoplasms 3Carcinoma, Renal Cell 3Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Chronic 2Kidney Neoplasms 2Bronchiolitis Obliterans Syndrome 2Blast Crisis 2Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1

Interventions

Cyclophosphamide 45fludarabine phosphate 39Peripheral Blood Stem Cell Transplantation 35Busulfan 34Antilymphocyte Serum 26Tacrolimus 25Cyclosporine 25Methotrexate 23Filgrastim 23Mycophenolic Acid 22Radiotherapy 21Melphalan 17Etoposide 15Cytarabine 15Whole-Body Irradiation 14Methylprednisolone 13Cord Blood Stem Cell Transplantation 12Azacitidine 9Specimen Handling 8Biopsy 8ruxolitinib 7Sirolimus 7Cyclosporins 7Alemtuzumab 7Thiotepa 6Decitabine 6sargramostim 5Rituximab 5fludarabine 4Tretinoin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Myelodysplastic-Myeloproliferative Diseases × Pentostatin × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00096161 2020-01-31

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
36 enrolled 13 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡